Medicis gets firm with Inamed; Mentor joins cosmetic industry leadership battle
This article was originally published in Clinica
Executive Summary
Medicis Pharmaceuticals, the skin care company slated to acquire Inamed, has taken a firm line with the breast implant maker, formally requesting that Inamed's shareholders either reject a recent acquisition proposal by Allergan or prepare to pay the $90m break-off fee to terminate its pending contract with Medicis.